Emerging ICT Challenges on Provision of Online HIV/AIDS Advisory Services

Author(s):  
Simon Samwel Msanjila

In order to address the research challenges related to spreading, prevention, and treatment of HIV/AIDS it is necessary to look at it from different angles. Considering a single aspect on established initiatives, such as technological or political concerns that have been adopted in research, leaves a “none complete and integrated picture” on challenges related to the provision of services for combating HIV/AIDS. This chapter addresses this aspect by considering a multi-perspective approach and proposes a set of challenges for each perspective. It also considers the technological perspective of provision of HIV/AIDS advisory services and presents challenges towards designing the proposed system.

2020 ◽  
Vol 17 (4) ◽  
pp. 448-456 ◽  
Author(s):  
Victor B. Oti

The use of Antiretroviral drugs in treating HIV/ AIDS patients has enormously increased their life spans with serious disadvantages. The virus infection still remains a public health problem worldwide with no cure and vaccine for the viral agent until now. The use of nanoparticles (NPs) for the treatment and prevention of HIV/AIDS is an emerging technology of the 21st century. NPs are solid and colloid particles with 10 nm to <1000 nm size range; although, less than 200 nm is the recommended size for nanomedical usage. There are NPs with therapeutic capabilities such as liposomes, micelles, dendrimers and nanocapsules. The particle enters the body mainly via oral intake, direct injection and inhalation. It has been proven to have potentials of advancing the prevention and treatment of the viral agent. Certain NPs have been shown to have selftherapeutic activity for the virus in vitro. Strategies that are novel are emerging which can be used to improve nanotechnology, such as genetic treatment and immunotherapy. In this review, nanoparticles, the types and its characteristics in drug delivery were discussed. The light was furthermore shed on its implications in the prevention and treatment of HIV/AIDS.


2009 ◽  
Vol 1 (2) ◽  
Author(s):  
Sharada Prasad Wasti ◽  
Padam Simkhada ◽  
Julian Randall ◽  
Edwin Van Teijlingen

The Lancet ◽  
2002 ◽  
Vol 360 (9326) ◽  
pp. 86-87 ◽  
Author(s):  
Eric Goemaere ◽  
Nathan Ford ◽  
Solomon R Benatar

Author(s):  
Kia Lilly Caldwell

Brazil has been long considered a global leader in HIV/AIDS prevention and treatment; however, little is known about the effectiveness of these prevention and treatment efforts for the Afro-Brazilian population. This chapter examines the shift toward greater government action focused on HIV prevention for Afro-Brazilians. The chapter also explores HIV prevention initiatives developed by black women’s organizations and how the dynamics of gender, race, and class shape HIV vulnerability for Afro-Brazilian women. Finally, this chapter examines critiques of racially specific HIV prevention initiatives and the tensions between universalism and race consciousness that have characterized the shift toward focusing on the black population in HIV prevention efforts.


The Lancet ◽  
2002 ◽  
Vol 360 (9326) ◽  
pp. 87 ◽  
Author(s):  
Gregg Gonsalves

2015 ◽  
Vol 20 (S1) ◽  
pp. 197-214 ◽  
Author(s):  
Linda M. Collins ◽  
Kari C. Kugler ◽  
Marya Viorst Gwadz

Sign in / Sign up

Export Citation Format

Share Document